<DOC>
	<DOCNO>NCT02642172</DOCNO>
	<brief_summary>The purpose present study evaluate whether prebiotics - ITF ( Inulin/OFS 75/25 ) effective treat patient non-alcoholic liver disease .</brief_summary>
	<brief_title>Prebiotics Patients With Non-alcoholic Liver Disease</brief_title>
	<detailed_description>The study include 60 patient Non-alcoholic fatty liver disease ( NAFLD ) randomize two group , receive either ITF ( Inulin/oligofructose-OFS 75/25 ) maltodextrin ( placebo ) . The trial last 20 week : Stage 1-Run-in period : Subjects follow ascertain weight maintenance . Stage 2- Randomized intervention period : Subjects assign receive 16 gram/day ITF maltodextrin . Both ITF placebo provide identical opaque package subject researcher blind content . Stage 3- Extension period : All patient receive 16 gram/day ITF 8 week . After sign informed consent , follow data collect : demographic , lifestyle habit include dietary questionnaire , medical history . At end week 2 , week 12 week 20 follow test perform : Vital Signs : blood pressure , anthropometric measurement , body composition determine bioelectrical impedance analysis ( BIA ) . Biochemical blood test : liver function test fast glucose insulin &amp; lipid profile , 75 gram oral glucose tolerance test ( OGTT ) , CRP ( inflammation marker ) , SCFA , BCAA , LBP FGF 19 . Fecal sample : fecal sample use microbiota composition analysis , BA analysis . Assessment liver status At week 2 , 12 , 20 use magnetic resonance spectroscopy ( 1H-MRS ) , SteatoTest NashTest ( FibroMax™ ) liver enzymes evaluate steohepatitis .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Diagnosis NAFLD base fatty infiltration detection ultrasonography alanine aminotransferase level ( ALT ) ≥ 30 U/L male ≥ 19 U/L female . Overweight ( BMI ≥ 27 kg/m2 ) fulfill criterion National Cholesterol Education Program ( NCEP ) metabolic syndrome Willing sign inform consent participate study Patients without diabetes wellcontrolled diabetes ( HbA1C &lt; 7.5 % ) treat diet ± metformin Pregnancy Uncontrolled diabetes Diabetic treatment metformin , unusual diet ( vegetarian , vegan ) , usage antibiotic , probiotic prebiotics 6 month prior study , alcohol abuse , presence gastrointestinal mental disorder , weightloss treatment , bariatric surgery Serious medical condition Evidence another etiology chronic liver disease : hepatitis B , hepatitis C , HIV , autoimmune disease metabolic disease , medication know hepatotoxicity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Inulin , OFS ( oligofructose )</keyword>
</DOC>